ATE192930T1 - Synthetische oberflächenaktive agentien auf der lunge - Google Patents

Synthetische oberflächenaktive agentien auf der lunge

Info

Publication number
ATE192930T1
ATE192930T1 AT91920210T AT91920210T ATE192930T1 AT E192930 T1 ATE192930 T1 AT E192930T1 AT 91920210 T AT91920210 T AT 91920210T AT 91920210 T AT91920210 T AT 91920210T AT E192930 T1 ATE192930 T1 AT E192930T1
Authority
AT
Austria
Prior art keywords
lung surfactant
temperature
composition
phosphatidylcholine
lamellar form
Prior art date
Application number
AT91920210T
Other languages
English (en)
Inventor
Andrew S Janoff
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of ATE192930T1 publication Critical patent/ATE192930T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91920210T 1990-10-17 1991-10-17 Synthetische oberflächenaktive agentien auf der lunge ATE192930T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59949390A 1990-10-17 1990-10-17
PCT/US1991/007746 WO1992006703A1 (en) 1990-10-17 1991-10-17 Synthetic lung surfactant

Publications (1)

Publication Number Publication Date
ATE192930T1 true ATE192930T1 (de) 2000-06-15

Family

ID=24399851

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91920210T ATE192930T1 (de) 1990-10-17 1991-10-17 Synthetische oberflächenaktive agentien auf der lunge

Country Status (11)

Country Link
EP (1) EP0553272B1 (de)
JP (1) JP3171445B2 (de)
KR (1) KR0181309B1 (de)
AT (1) ATE192930T1 (de)
AU (1) AU650303B2 (de)
CA (1) CA2093133C (de)
DE (1) DE69132211T2 (de)
DK (1) DK0553272T3 (de)
ES (1) ES2146580T3 (de)
GR (1) GR3034211T3 (de)
WO (1) WO1992006703A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120005D0 (en) * 1991-09-19 1991-11-06 Wellcome Found Method of administering phospholipid dispersions
EP0877602B1 (de) 1996-01-24 2002-01-23 Byk Gulden Lomberg Chemische Fabrik GmbH Verfahren zur herstellung von pulverförmigen lungensurfactant-zubereitungen
WO1997035559A2 (en) * 1996-03-27 1997-10-02 Ortho Pharmaceutical Corporation Manufacture of liposomes and lipid-protein complexes by ethanolic injection and thin film evaporation
WO2003077891A1 (fr) * 2002-03-18 2003-09-25 Yamanouchi Pharmaceutical Co., Ltd. Compositions medicales en poudre pour inhalation et procede de production de celles-ci
MX2013001936A (es) 2010-08-23 2013-03-08 Takeda Gmbh Particulas humidificadas que comprenden una sustancia terapeuticamente activa.
AU2015226287B2 (en) 2014-03-05 2019-01-31 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Humidifier for humidifying an aerosol
AU2015226289B8 (en) 2014-03-05 2019-10-31 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device for providing a constant amount of aerosol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5795920A (en) * 1980-12-04 1982-06-15 Teijin Ltd Remedy for respiratory disease
US4915951A (en) * 1987-12-03 1990-04-10 California Institute Of Technology Cryoprotective reagent

Also Published As

Publication number Publication date
EP0553272B1 (de) 2000-05-17
JP3171445B2 (ja) 2001-05-28
CA2093133C (en) 1999-03-30
EP0553272A1 (de) 1993-08-04
DK0553272T3 (da) 2000-09-04
EP0553272A4 (en) 1994-09-07
KR0181309B1 (ko) 1999-03-20
CA2093133A1 (en) 1992-04-18
GR3034211T3 (en) 2000-12-29
WO1992006703A1 (en) 1992-04-30
DE69132211T2 (de) 2000-11-23
ES2146580T3 (es) 2000-08-16
JPH06502427A (ja) 1994-03-17
AU650303B2 (en) 1994-06-16
AU8929191A (en) 1992-05-20
DE69132211D1 (de) 2000-06-21

Similar Documents

Publication Publication Date Title
Taeusch et al. Characterization of bovine surfactant for infants with respiratory distress syndrome
US5614216A (en) Synthetic lung surfactant
EP0100910B1 (de) Lungensurfactant
CA2096537C (en) Method of administering dipalmitoylphosphatidylcholine dispersions
KR101516443B1 (ko) 개선된 특성을 가지는 재구성된 계면활성제
JP5065047B2 (ja) 肺表面活性物質の配合物
ES2004856T3 (es) Agente tensioactivo pulmonar natural, procedimiento de preparacion y composiciones farmaceuticas.
AU690520B2 (en) Prophylactic and remedy for viral diseases in respiratory tract
PT1841458E (pt) Regime de tratamento com surfactante para tratar ou prevenir displasia broncopulmonar
US6770619B2 (en) Lung surfactant compositions with dynamic swelling behavior
EP0092121B1 (de) Verfahren und Zusammensetzungen zur Behandlung von Magen- und Darm-Ulcus
EA001758B1 (ru) Композиции для лечения респираторного дистресс-синдрома взрослых или респираторного дистресс-синдрома новорожденных, содержащие 3-(циклопропилметокси)-n-(3,5-дихлор-4-пиридинил)-4-(дифторметокси)бензамид и легочное поверхностно-активное вещество
ATE192930T1 (de) Synthetische oberflächenaktive agentien auf der lunge
EP0528034A1 (de) Asthma heilmittel
JP2003522138A (ja) 慢性肺疾患の予防および治療のための肺表面活性剤の新規使用
EP2538960B1 (de) Tensidzusammensetzungen enthaltend polypeptidkomplexe
Liu et al. Characterization of plasma-stabilized liposomes composed of dioleoylphosphatidylethanolamine and oleic acid
UA26313A (uk) Засіб для замісhої терапії захворюваhь дихальhих шляхів, переважhо при сиhдромі задухи
McLean et al. Biomimetic pulmonary surfactants
ES2092969A1 (es) Surfactante pulmonar natural de origen porcino.
KR970074792A (ko) 합성 펩타이드를 이용한 폐 계면활성제
JP2001089391A (ja) Irdsおよびaliの治療用の製薬的組成物、その使用、およびそれを有する製品
Vora et al. Effects of drugs on mucociliary activity in humans

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee